A HER2-targeted antibody-novel DNA topoisomerase I inhibitor conjugate induces durable adaptive antitumor immunity by activating dendritic cells

• Main Authors: Xiaoding Tan (Author), Peng Fang (Author), Kaiying Li (Author), Meng You (Author), Yuxia Cao (Author), Hui Xu (Author), Xiaohong Zhu (Author), Lu Wang (Author), Xin Wei (Author), Haiying Wen (Author), Wendi Li (Author), Lei Shi (Author), Xiaowei Sun (Author), Dongan Yu (Author), Huikai Zhu (Author), Zhenzhen Wang (Author), Datao Liu (Author), Hui Shen (Author), Wei Zhou (Author), Maomao An (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ABSTRACTWe designed and developed a novel DNA topoisomerase I inhibitor MF-6, which was a more potent cytotoxin and a more potent inducer of immunogenic cell death compared with DXd. To utilize MF-6's ability to induce antitumor immunity, a human epidermal growth factor receptor 2 (HER2)-target...